Literature DB >> 7561797

Hepatitis E virus antibodies among patients with hemophilia, blood donors, and hepatitis patients.

H L Zaaijer1, E P Mauser-Bunschoten, J H ten Veen, H P Kapprell, M Kok, H M van den Berg, P N Lelie.   

Abstract

The presence of antibodies to hepatitis E virus (HEV) was studied among hemophiliacs, blood donors, and hepatitis patients. Four of 296 (1.4%) hemophiliacs and 5 of 1,275 (0.4%) donors were confirmed as positive for HEV antibodies (difference was not significant: P = 0.07). Parenteral transmission of HEV to hemophiliacs was thus rare or nonexistent. Seven of 187 hepatitis patients were found with HEV antibodies (IgG and IgM). Six persons fell ill shortly after arriving from HEV-endemic countries. The seventh patient, without a history of travel, represents a case of nontropical hepatitis E. Consequently, hepatitis E should be considered in patients suffering from acute non-ABC hepatitis, even in industrialized countries.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7561797     DOI: 10.1002/jmv.1890460313

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  10 in total

1.  Hepatitis E Virus.

Authors: 
Journal:  Transfus Med Hemother       Date:  2009       Impact factor: 3.747

2.  Transmission of hepatitis E in Germany.

Authors:  W J Hartmann; G G Frösner; D Eichenlaub
Journal:  Infection       Date:  1998 Nov-Dec       Impact factor: 3.553

3.  Hepatitis E Virus.

Authors:  Georg Pauli; Johannes Blümel; Reinhard Burger; Christian Drosten; Albrecht Gröner; Lutz Gürtler; Margarethe Heiden; Martin Hildebrandt; Bernd Jansen; Horst Klamm; Thomas Montag-Lessing; Ruth Offergeld; Rainer Seitz; Uwe Schlenkrich; Volkmar Schottstedt; Hannelore Willkommen; Carl-Heinz Wirsing von König
Journal:  Transfus Med Hemother       Date:  2008-01-18       Impact factor: 3.747

4.  Hepatitis E Virus.

Authors:  Georg Pauli; Martin Aepfelbacher; Ursula Bauerfeind; Johannes Blümel; Reinhard Burger; Barbara Gärtner; Albrecht Gröner; Lutz Gürtler; Margarethe Heiden; Martin Hildebrandt; Bernd Jansen; Ruth Offergeld; Uwe Schlenkrich; Volkmar Schottstedt; Rainer Seitz; Johanna Strobel; Hannelore Willkommen; Sally A Baylis
Journal:  Transfus Med Hemother       Date:  2015-06-01       Impact factor: 3.747

5.  Prevalence of hepatitis E virus antibodies in Canadian swine herds and identification of a novel variant of swine hepatitis E virus.

Authors:  D Yoo; P Willson; Y Pei; M A Hayes; A Deckert; C E Dewey; R M Friendship; Y Yoon; M Gottschalk; C Yason; A Giulivi
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

6.  Evidence of extrahepatic sites of replication of the hepatitis E virus in a swine model.

Authors:  T P Williams; C Kasorndorkbua; P G Halbur; G Haqshenas; D K Guenette; T E Toth; X J Meng
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

7.  Identity of a novel swine hepatitis E virus in Taiwan forming a monophyletic group with Taiwan isolates of human hepatitis E virus.

Authors:  S Y Hsieh; X J Meng; Y H Wu; S T Liu; A W Tam; D Y Lin; Y F Liaw
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

8.  Genetic and experimental evidence for cross-species infection by swine hepatitis E virus.

Authors:  X J Meng; P G Halbur; M S Shapiro; S Govindarajan; J D Bruna; I K Mushahwar; R H Purcell; S U Emerson
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

9.  Systematic review and meta-analysis of the seroprevalence of hepatitis E virus in the general population across non-endemic countries.

Authors:  Barbara Wilhelm; Lisa Waddell; Judy Greig; Ian Young
Journal:  PLoS One       Date:  2019-06-07       Impact factor: 3.240

10.  Non-travel related Hepatitis E virus genotype 3 infections in the Netherlands; a case series 2004 - 2006.

Authors:  Katrine Borgen; Tineke Herremans; Erwin Duizer; Harry Vennema; Saskia Rutjes; Arnold Bosman; Ana Maria de Roda Husman; Marion Koopmans
Journal:  BMC Infect Dis       Date:  2008-05-08       Impact factor: 3.090

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.